Case Studies/Studies

Can the Development of Pediatric Asthma Be Prevented?

A new study led by researchers at Boston Children’s Hospital aims to determine whether monoclonal antibody Xolair (omalizumab) can stop or lessen the progression of asthma in high-risk children.


The Housing and Health Connection

As the affordable housing crisis worsens across the country, research shows that ensuring housing stability has a big impact on health outcomes.


Could the End of MS Be on the Horizon?

As a new longitudinal study shows a definitive connection between the Epstein-Barr virus and multiple sclerosis, research turns to vaccines, new treatments — and the further roots of what causes the disease.


Endometriosis May Not Cause Preterm Births

New research found no difference in rates of preterm births after adjusting for other risk factors.


Novel Monoclonal Antibody Could Transform High-Risk Neuroblastoma Treatment

Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.


Connecting MS, Depression, Vascular Disease and Mortality

New retrospective research indicates depression management may lower mortality rates among those with MS.


Increased Myocarditis Reported in Patients Receiving Immune Checkpoint Inhibitors

New data indicates patients report myocarditis at higher rates after the use of immune checkpoint inhibitors during cancer treatment.


Israel-Based Research Defines Myocarditis Risk Following Pfizer-BioNTech Vaccination

Evidence indicates the strongest connection between the vaccination and myocarditis is among males ages 16 to 29.


Improving Cardiac Outcomes Through Bariatric Surgery

The link between obesity and cardiovascular health is well established. Until recent years, however, it was unclear whether bariatric surgery could improve morbidity and mortality among obese individuals who had already experienced significant cardiovascular events.

...


Microbubbles May Boost Response to Transarterial Radioembolization for the Most Common Form of Liver Cancer

In a first-of-its-kind clinical trial, researchers at Thomas Jefferson University demonstrated the safety of combining ultrasound-triggered microbubble destruction and transarterial radioembolization (TARE) to treat patients with hepatocellular carcinoma — and found that combining the therapies was nearly twice as effective as TARE alone.